Cibus, Inc. (NASDAQ:CBUS) Short Interest Update

Cibus, Inc. (NASDAQ:CBUS) was the recipient of a significant increase in short interest in December. As of December 31st, there was short interest totaling 1,080,944 shares, an increase of 32.4% from the December 15th total of 816,246 shares. Based on an average daily trading volume, of 163,460 shares, the days-to-cover ratio is presently 6.6 days. Approximately 3.9% of the shares of the stock are short sold. Approximately 3.9% of the shares of the stock are short sold. Based on an average daily trading volume, of 163,460 shares, the days-to-cover ratio is presently 6.6 days.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. Weiss Ratings restated a “sell (e+)” rating on shares of Cibus in a research report on Wednesday, October 8th. Canaccord Genuity Group restated a “buy” rating and issued a $15.00 price target on shares of Cibus in a report on Monday, December 8th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $20.00.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. Rockland Trust Co. acquired a new position in Cibus during the third quarter worth approximately $26,000. Qube Research & Technologies Ltd acquired a new position in shares of Cibus in the 2nd quarter valued at $39,000. Warberg Asset Management LLC purchased a new stake in shares of Cibus during the 2nd quarter valued at $41,000. FNY Investment Advisers LLC acquired a new stake in shares of Cibus during the 2nd quarter worth $54,000. Finally, Squarepoint Ops LLC purchased a new position in shares of Cibus in the 3rd quarter worth $62,000. 33.81% of the stock is currently owned by hedge funds and other institutional investors.

Cibus Stock Performance

CBUS stock traded up $0.04 during trading on Friday, hitting $1.90. The stock had a trading volume of 280,072 shares, compared to its average volume of 251,027. Cibus has a 1-year low of $1.09 and a 1-year high of $3.40. The stock has a market cap of $103.14 million, a price-to-earnings ratio of -0.58 and a beta of 1.57. The company’s 50 day moving average price is $1.61 and its two-hundred day moving average price is $1.52.

Cibus (NASDAQ:CBUS) last announced its earnings results on Thursday, November 13th. The company reported ($0.44) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.41) by ($0.03). Cibus had a negative return on equity of 133.90% and a negative net margin of 3,133.92%.The firm had revenue of $0.62 million for the quarter, compared to analyst estimates of $1.39 million. As a group, sell-side analysts forecast that Cibus will post -2.96 earnings per share for the current fiscal year.

About Cibus

Cibus, Inc is a biotechnology company specializing in precision gene editing for agricultural applications. Leveraging its proprietary Rapid Trait Development System (RTDS), Cibus develops improved crop traits without the introduction of foreign DNA. The company’s platform enables targeted modifications to plant genomes, allowing for enhanced disease resistance, herbicide tolerance and yield optimization in key row crops.

The company’s core business centers on trait development services and licensing partnerships.